Vestcor Inc bought a new stake in shares of SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 48,177 shares of the company’s stock, valued at approximately $290,000. Vestcor Inc owned 0.07% of SIGA Technologies as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Ashton Thomas Private Wealth LLC bought a new stake in shares of SIGA Technologies in the fourth quarter valued at approximately $422,000. Victory Capital Management Inc. raised its stake in SIGA Technologies by 19.0% during the 4th quarter. Victory Capital Management Inc. now owns 308,498 shares of the company’s stock valued at $1,854,000 after purchasing an additional 49,355 shares during the last quarter. Bailard Inc. raised its stake in SIGA Technologies by 31.5% during the 4th quarter. Bailard Inc. now owns 18,800 shares of the company’s stock valued at $113,000 after purchasing an additional 4,500 shares during the last quarter. Denali Advisors LLC boosted its holdings in SIGA Technologies by 58.3% in the 4th quarter. Denali Advisors LLC now owns 378,544 shares of the company’s stock valued at $2,275,000 after purchasing an additional 139,354 shares during the period. Finally, Bank of New York Mellon Corp grew its position in SIGA Technologies by 52.4% in the 4th quarter. Bank of New York Mellon Corp now owns 289,712 shares of the company’s stock worth $1,741,000 after purchasing an additional 99,670 shares during the last quarter. Institutional investors and hedge funds own 55.40% of the company’s stock.
SIGA Technologies Stock Performance
Shares of SIGA opened at $5.63 on Tuesday. The company has a 50-day simple moving average of $5.96 and a 200-day simple moving average of $6.60. SIGA Technologies, Inc. has a 52 week low of $5.16 and a 52 week high of $12.83. The firm has a market capitalization of $402.19 million, a P/E ratio of 4.69 and a beta of 0.98.
SIGA Technologies Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Recommended Stories
- Five stocks we like better than SIGA Technologies
- What Investors Need to Know About Upcoming IPOs
- Can TikTok Stock Picks Really Make You Rich?
- Stock Market Upgrades: What Are They?
- The “Quality” Rotation: Back to Basics Investing
- What is MarketRankā¢? How to Use it
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.